- This was the first undergraduate Pharmaceutical Science degree accredited by The Organisation for Professionals in Regulatory Affairs (TOPRA) in the UK. Consequently, graduates with this degree will be highly sought-after by employers.- This course was shortlisted for the Guardian University Award for Course Design, Retention and Student Outcomes and the TOPRA Regulatory Excellence Award in Education 2020.- You’ll gain extensive practical experience in new laboratories after a £6.8 million investment.- Our commitment to high quality teaching has been recognised with a Teaching Excellence Framework (TEF) Gold rating. The University has received an overall rating of Gold, as well as securing a Gold award in the framework's two new student experience and student outcomes categories.

How do we ensure new drugs are safe for the public, correctly evaluated and their use properly regulated? Regulatory Affairs is an area of growing opportunity in the pharmaceutical industry. This course focuses on public health and the introduction of drugs. You’ll learn to produce legal applications for new drug licences, deal with different regulatory authorities and ensure drug safety. The course also offers a practical understanding of the pharmaceutical industry. You’ll explore different sources of medicine, how they work and how they’re made, packaged and administered.

Embedded within every course curriculum and throughout the whole Kingston experience, Future Skills will play a role in shaping you to become a future-proof graduate, providing you with the skills most valued by employers such as problem-solving, digital competency, and adaptability. As you progress through your degree, you'll learn to navigate, explore and apply these graduate skills, learning to demonstrate and articulate to employers how future skills give you the edge. At Kingston University, we're not just keeping up with change, we're creating it.

Graduates are successful in careers such as Regulatory Affairs, drug development, quality control, clinical trials and research, drug safety and pharmacovigilance.